AUTOLOGOUS CD34+ CELLS ENCODING .BETA.A-T87Q-GLOBIN GENE
Fanconi Anemia Complementation Group A
Rocket Pharmaceuticals Inc.Cell therapyActive
D
30/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 15/ 100
- Competitive Position
- 95/ 100
Competitive context
0 Active assets in the Fanconi Anemia Complementation Group A cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
MOZAFANCOGENE AUTOTEMCEL Rocket Pharmaceuticals Inc. | Phase 2 | CCC |
Same molecule, other indications
AUTOLOGOUS CD34+ CELLS ENCODING .BETA.A-T87Q-GLOBIN GENE is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →